Feasibility of allogeneic mesenchymal stem cells in pediatric hypoxic-ischemic encephalopathy: Phase I study

BACKGROUND: Hypoxic-ischemic encephalopathy (HIE) is one of the leading causes of death and long-term neurological impairment in the pediatric population. Despite a limited number of treatments to cure HIE, stem cell therapies appear to be a potential treatment option for brain injury resulting from...

Descripción completa

Detalles Bibliográficos
Autores principales: Kabatas, Serdar, Civelek, Erdinç, Savrunlu, Eyüp Can, Kaplan, Necati, Boyalı, Osman, Diren, Furkan, Can, Halil, Genç, Ali, Akkoç, Tunç, Karaöz, Erdal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176840/
https://www.ncbi.nlm.nih.gov/pubmed/34136076
http://dx.doi.org/10.4252/wjsc.v13.i5.470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176840/
https://www.ncbi.nlm.nih.gov/pubmed/34136076
http://dx.doi.org/10.4252/wjsc.v13.i5.470

Ejemplares similares